Literature DB >> 20349100

D-dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: analysis of 194 cases.

Heng-Li Tian1, Hao Chen, Bing-Shan Wu, He-Li Cao, Tao Xu, Jin Hu, Gan Wang, Wen-Wei Gao, Zai-Kai Lin, Shi-Wen Chen.   

Abstract

This study sought to describe and evaluate any relationship between D-dimer values and progressive hemorrhagic injury (PHI) after traumatic brain injury (TBI). In patients with TBI, plasma D-dimer was measured while a computed tomography (CT) scan was conducted as soon as the patient was admitted to the emergency department. A series of other clinical and laboratory parameters were also measured and recorded. A logistic multiple regression analysis was used to identify risk factors for PHI. A cohort of 194 patients with TBI was evaluated in this clinical study. Eighty-one (41.8%) patients suffered PHI as determined by a second CT scan. The plasma D-dimer level was higher in patients who demonstrated PHI compared with those who did not (P < 0.001. Using a receiver-operator characteristic curve to predict the possibility by measuring the D-dimer level, a value of 5.00 mg/L was considered the cutoff point, with a sensitivity of 72.8% and a specificity of 78.8%. Eight-four patients had D-dimer levels higher than the cut point value (5.0 mg/L); PHI was seen in 71.4% of these patients and in 19.1% of the other patients (P < 0.01). Factors with P < 0.2 on bivariate analysis were included in a stepwise logistic regression analysis to identify independent risk factors for TBI coagulopathy. Logistic regression analysis showed that the D-dimer value was a predictor of PHI, and the odds ratio (OR) was 1.341 with per milligram per liter (P = 0.020). The stepwise logistic regression also identified that time from injury to the first CT shorter than 2 h (OR = 2.118, P = 0.047), PLT counts lesser than 100 x 109/L (OR = 7.853, P = 0.018), and Fg lower than 2.0 g/L (OR = 3.001, P = 0.012) were risk factors for the development of PHI. When D-dimer values were dichotomized at 5 mg/L, time from injury to the first CT scan was no longer a risk factor statistically while the OR value of D-dimer to the occurrence of PHI elevated to 11.850(P < 0.001). The level of plasma D-dimer after TBI can be a useful prognostic factor for PHI and should be considered in the clinical management of patients in combination with neuroimaging and other data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349100     DOI: 10.1007/s10143-010-0251-z

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  29 in total

Review 1.  Disseminated intravascular coagulation.

Authors:  M Levi; H Ten Cate
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 2.  A systematic review of brain injury epidemiology in Europe.

Authors:  F Tagliaferri; C Compagnone; M Korsic; F Servadei; J Kraus
Journal:  Acta Neurochir (Wien)       Date:  2006-03       Impact factor: 2.216

Review 3.  Guidelines for the management of severe head injury. Brain Trauma Foundation.

Authors:  R Bullock; R M Chesnut; G Clifton; J Ghajar; D W Marion; R K Narayan; D W Newell; L H Pitts; M J Rosner; J W Wilberger
Journal:  Eur J Emerg Med       Date:  1996-06       Impact factor: 2.799

4.  Posttraumatic cerebral hemispheric swelling. Analysis of 55 cases studied with computerized tomography.

Authors:  R D Lobato; R Sarabia; F Cordobes; J J Rivas; A Adrados; A Cabrera; P Gomez; A Madera; E Lamas
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

5.  Posttraumatic cerebral infarction diagnosed by CT: prevalence, origin, and outcome.

Authors:  S E Mirvis; A L Wolf; Y Numaguchi; G Corradino; J N Joslyn
Journal:  AJR Am J Roentgenol       Date:  1990-06       Impact factor: 3.959

6.  Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination.

Authors:  Matthew M Carrick; Alan H Tyroch; Cortney A Youens; Taylor Handley
Journal:  J Trauma       Date:  2005-04

7.  Coagulopathy as a parameter to predict the outcome in head injury patients--analysis of 61 cases.

Authors:  Jinn-Rung Kuo; Tsung-Jer Chou; Chung-Ching Chio
Journal:  J Clin Neurosci       Date:  2004-09       Impact factor: 1.961

8.  Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro.

Authors:  S C Robson; E G Shephard; R E Kirsch
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

9.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

10.  Evolving brain lesions in the first 12 hours after head injury: analysis of 37 comatose patients.

Authors:  F Servadei; A Nanni; M T Nasi; D Zappi; G Vergoni; G Giuliani; A Arista
Journal:  Neurosurgery       Date:  1995-11       Impact factor: 4.654

View more
  23 in total

Review 1.  Hemorrhagic progression of a contusion after traumatic brain injury: a review.

Authors:  David Kurland; Caron Hong; Bizhan Aarabi; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

2.  A risk score based on admission characteristics to predict progressive hemorrhagic injury from traumatic brain injury in children.

Authors:  Guo-Wen Hu; Hai-Li Lang; Hua Guo; Lei Wu; Pei Zhang; Wei Kuang; Xin-Gen Zhu
Journal:  Eur J Pediatr       Date:  2017-03-25       Impact factor: 3.183

3.  Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury.

Authors:  Victoria A Ploplis; Deborah L Donahue; Mayra J Sandoval-Cooper; Maria MorenoCaffaro; Patrick Sheets; Scott G Thomas; Mark Walsh; Francis J Castellino
Journal:  J Neurotrauma       Date:  2014-05-21       Impact factor: 5.269

4.  High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma.

Authors:  D H Lee; B K Lee; S M Noh; Y S Cho
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-18       Impact factor: 3.693

5.  Severe traumatic brain injury is associated with a unique coagulopathy phenotype.

Authors:  Jason M Samuels; Ernest E Moore; Christopher C Silliman; Anirban Banerjee; Mitchell J Cohen; Arsen Ghasabyan; James Chandler; Julia R Coleman; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2019-04       Impact factor: 3.313

Review 6.  Coagulopathy associated with traumatic brain injury.

Authors:  Monisha A Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

7.  The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.

Authors:  Michael V DeFazio; Richard A Rammo; Jaime R Robles; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  World Neurosurg       Date:  2013-01-08       Impact factor: 2.104

8.  Traumatic brain injury associated coagulopathy.

Authors:  Airton Leonardo de Oliveira Manoel; Antonio Capone Neto; Precilla V Veigas; Sandro Rizoli
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

9.  Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury.

Authors:  Pierre Esnault; Quentin Mathais; Erwan D'Aranda; Ambroise Montcriol; Mickaël Cardinale; Pierre-Julien Cungi; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Eric Meaudre
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

10.  Predicting progressive hemorrhagic injury after traumatic brain injury: derivation and validation of a risk score based on admission characteristics.

Authors:  Fang Yuan; Jun Ding; Hao Chen; Yan Guo; Gan Wang; Wen-Wei Gao; Shi-Wen Chen; Heng-Li Tian
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.